H. Shaw Warren
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
H. Shaw Warren has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Judith Hellman
Department of Anesthesia and Critical Care, Massachusetts General Hospital , Boston
3 shared publicationsGuangjie Sun
Infectious Disease Unit, Massachusetts General Hospital , Boston
2 shared publicationsTian Lin
Infectious Disease Unit, Massachusetts General Hospital, Boston, MA 02129, USA
2 shared publicationsXueya Liang
Infectious Disease Unit, Massachusetts General Hospital , Boston
2 shared publicationsAranya Bagchi
Department of Anesthesia and Critical Care, Massachusetts General Hospital, Boston, USA
1 shared publicationBarbara G. Paton
Microbiology Laboratory, Massachusetts Eye and Ear Infirmary, Boston
1 shared publication
Latest Publications
- Open Access
- 1 March 2011
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 89 (3) , 325-326
Editorial: Control issues in sepsis: what modulates apoptosis?
Vaki et al. propose that there may be factor(s) in the serum of patients with severe sepsis that modulate apoptosis of lymphocytes and monocytes.
- 1 March 2011
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 89 (3) , 325-326
Open AccessEditorial: Control issues in sepsis: what modulates apoptosis?
Vaki et al. propose that there may be factor(s) in the serum of patients with severe sepsis that modulate apoptosis of lymphocytes and monocytes.
- Open Access
- 15 August 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (4) , 624-632
Synergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll‐Like Receptor Agonists and Is Blocked by Hemopexin
Detection of microbial components by immune cells via Toll-like receptors (TLRs) with subsequent induction of inflammation is essential for host defe
- 15 August 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 202 (4) , 624-632
Open AccessSynergistic Inflammation Is Induced by Blood Degradation Products with Microbial Toll‐Like Receptor Agonists and Is Blocked by Hemopexin
Detection of microbial components by immune cells via Toll-like receptors (TLRs) with subsequent induction of inflammation is essential for host defe
- Open Access
- 15 January 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (2) , 223-232
Resilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in Serum
Vertebrates vary in resistance and resilience to infectious diseases, and the mechanisms that regulate the tradeoff between these often opposing prot
- 15 January 2010
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 201 (2) , 223-232
Open AccessResilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in Serum
Vertebrates vary in resistance and resilience to infectious diseases, and the mechanisms that regulate the tradeoff between these often opposing prot
- Open Access
- 1 August 2009
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 86 (2) , 199-201
Editorial: Mouse models to study sepsis syndrome in humans
Journal of Leukocyte Biology considers manuscripts of original investigations focusing on the origins, developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes, and other cells involved in host defense. These include full-length papers on original research, rapid communications of new discoveries, letters, commentaries, and invited reviews.
- 1 August 2009
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 86 (2) , 199-201
Open AccessEditorial: Mouse models to study sepsis syndrome in humans
Journal of Leukocyte Biology considers manuscripts of original investigations focusing on the origins, developmental biology, biochemistry and functions of granulocytes, lymphocytes, mononuclear phagocytes, and other cells involved in host defense. These include full-length papers on original research, rapid communications of new discoveries, letters, commentaries, and invited reviews.
- Open Access
- 24 April 2009
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 86 (2) , 229-235
Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages
The heme-binding protein hemopexin limits TLR4 and TLR2 agonist-induced macrophage cytokine production through a mechanism distinct from heme oxygenase-1. Detection of LPS in tissues is an integral component of innate immunity that acts to protect against invasion by Gram-negative bacteria. Plasma down-regulates LPS-induced cytokine production from macrophages, thereby limiting systemic inflammation in blood and distant tissues. To identify the protein(s) involved in this process, we used classical biochemical chromatographic techniques to identify fractions of mouse sera that suppress LPS-induced TNF from bone marrow-derived macrophages (BMDMs). Fractionation yielded microgram quantities of a protein that was identified by MS to be hemopexin (Hx). Mouse Hx purified on hemin-agarose beads and rhHx decreased the production of cytokines from BMDMs and peritoneal macrophages induced by LPS. Preincubation of LPS with Hx did not affect the activity of LPS on LAL, whereas preincubation of Hx with macrophages followed by washing resulted in decreased activity of these cells in response to LPS, suggesting that Hx acts on macrophages rather than LPS. Heme-free Hx did not stimulate HO-1 in the macrophages. Purified Hx also decreased TNF and IL-6 from macrophages induced by the synthetic TLR2 agonist Pam3Cys. Our data suggest that Hx, which is an acute-phase protein that increases during inflammation, limits TLR4 and TLR2 agonist-induced macrophage cytokine production directly through a mechanism distinct from HO-1.
- 24 April 2009
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 86 (2) , 229-235
Open AccessHemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages
The heme-binding protein hemopexin limits TLR4 and TLR2 agonist-induced macrophage cytokine production through a mechanism distinct from heme oxygenase-1. Detection of LPS in tissues is an integral component of innate immunity that acts to protect against invasion by Gram-negative bacteria. Plasma down-regulates LPS-induced cytokine production from macrophages, thereby limiting systemic inflammation in blood and distant tissues. To identify the protein(s) involved in this process, we used classical biochemical chromatographic techniques to identify fractions of mouse sera that suppress LPS-induced TNF from bone marrow-derived macrophages (BMDMs). Fractionation yielded microgram quantities of a protein that was identified by MS to be hemopexin (Hx). Mouse Hx purified on hemin-agarose beads and rhHx decreased the production of cytokines from BMDMs and peritoneal macrophages induced by LPS. Preincubation of LPS with Hx did not affect the activity of LPS on LAL, whereas preincubation of Hx with macrophages followed by washing resulted in decreased activity of these cells in response to LPS, suggesting that Hx acts on macrophages rather than LPS. Heme-free Hx did not stimulate HO-1 in the macrophages. Purified Hx also decreased TNF and IL-6 from macrophages induced by the synthetic TLR2 agonist Pam3Cys. Our data suggest that Hx, which is an acute-phase protein that increases during inflammation, limits TLR4 and TLR2 agonist-induced macrophage cytokine production directly through a mechanism distinct from HO-1.
- Open Access
- 10 April 2009
- Published by Springer Nature in Molecular Medicine
- Vol. 15 (7-8) , 220-227
A Genomic Score Prognostic of Outcome in Trauma Patients
Traumatic injuries frequently lead to infection, organ failure, and death. Health care providers rely on several injury scoring systems to quantify the extent of injury and to help predict clinical outcome. Physiological, anatomical, and clinical laboratory analytic scoring systems (Acute Physiology and Chronic Health Evaluation [APACHE], Injury Severity Score [ISS]) are utilized, with limited success, to predict outcome following injury. The recent development of techniques for measuring the expression level of all of a person's genes simultaneously may make it possible to develop an injury scoring system based on the degree of gene activation. We hypothesized that a peripheral blood leukocyte gene expression score could predict outcome, including multiple organ failure, following severe blunt trauma. To test such a scoring system, we measured gene expression of peripheral blood leukocytes from patients within 12 h of traumatic injury. cRNA derived from whole blood leukocytes obtained within 12 h of injury provided gene expression data for the entire genome that were used to create a composite gene expression score for each patient. Total blood leukocytes were chosen because they are active during inflammation, which is reflective of poor outcome. The gene expression score combines the activation levels of all the genes into a single number which compares the patient's gene expression to the average gene expression in uninjured volunteers. Expression profiles from healthy volunteers were averaged to create a reference gene expression profile which was used to compute a difference from reference (DFR) score for each patient. This score described the overall genomic response of patients within the first 12 h following severe blunt trauma. Regression models were used to compare the association of the DFR, APACHE, and ISS scores with outcome. We hypothesized that patients with a total gene response more different from uninjured volunteers would tend to have poorer outcome than those more similar. Our data show that for measures of poor outcome, such as infections, organ failures, and length of hospital stay, this is correct. DFR scores were associated significantly with adverse outcome, including multiple organ failure, duration of ventilation, length of hospital stay, and infection rate. The association remained significant after adjustment for injury severity as measured by APACHE or ISS. A single score representing changes in gene expression in peripheral blood leukocytes within hours of severe blunt injury is associated with adverse clinical outcomes that develop later in the hospital course. Assessment of genome-wide gene expression provides useful clinical information that is different from that provided by currently utilized anatomic or physiologic scores.
- 10 April 2009
- Published by Springer Nature in Molecular Medicine
- Vol. 15 (7-8) , 220-227
Open AccessA Genomic Score Prognostic of Outcome in Trauma Patients
Traumatic injuries frequently lead to infection, organ failure, and death. Health care providers rely on several injury scoring systems to quantify the extent of injury and to help predict clinical outcome. Physiological, anatomical, and clinical laboratory analytic scoring systems (Acute Physiology and Chronic Health Evaluation [APACHE], Injury Severity Score [ISS]) are utilized, with limited success, to predict outcome following injury. The recent development of techniques for measuring the expression level of all of a person's genes simultaneously may make it possible to develop an injury scoring system based on the degree of gene activation. We hypothesized that a peripheral blood leukocyte gene expression score could predict outcome, including multiple organ failure, following severe blunt trauma. To test such a scoring system, we measured gene expression of peripheral blood leukocytes from patients within 12 h of traumatic injury. cRNA derived from whole blood leukocytes obtained within 12 h of injury provided gene expression data for the entire genome that were used to create a composite gene expression score for each patient. Total blood leukocytes were chosen because they are active during inflammation, which is reflective of poor outcome. The gene expression score combines the activation levels of all the genes into a single number which compares the patient's gene expression to the average gene expression in uninjured volunteers. Expression profiles from healthy volunteers were averaged to create a reference gene expression profile which was used to compute a difference from reference (DFR) score for each patient. This score described the overall genomic response of patients within the first 12 h following severe blunt trauma. Regression models were used to compare the association of the DFR, APACHE, and ISS scores with outcome. We hypothesized that patients with a total gene response more different from uninjured volunteers would tend to have poorer outcome than those more similar. Our data show that for measures of poor outcome, such as infections, organ failures, and length of hospital stay, this is correct. DFR scores were associated significantly with adverse outcome, including multiple organ failure, duration of ventilation, length of hospital stay, and infection rate. The association remained significant after adjustment for injury severity as measured by APACHE or ISS. A single score representing changes in gene expression in peripheral blood leukocytes within hours of severe blunt injury is associated with adverse clinical outcomes that develop later in the hospital course. Assessment of genome-wide gene expression provides useful clinical information that is different from that provided by currently utilized anatomic or physiologic scores.
- Open Access
- 1 September 2006
- Published by Springer Nature in Molecular Medicine
- Vol. 12 (9-10) , 252-258
Passive Immunization to Outer Membrane Proteins MLP and PAL Does Not Protect Mice from Sepsis
Multiple older studies report that immunoglobulin directed to rough mutant bacteria, such as E. coli J5, provides broad protection against challenge with h
- 1 September 2006
- Published by Springer Nature in Molecular Medicine
- Vol. 12 (9-10) , 252-258
Open AccessPassive Immunization to Outer Membrane Proteins MLP and PAL Does Not Protect Mice from Sepsis
Multiple older studies report that immunoglobulin directed to rough mutant bacteria, such as E. coli J5, provides broad protection against challenge with h
- Open Access
- 1 November 2003
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 188 (9) , 1382-1393
Protective Efficacy of CAP18106–138–Immunoglobulin G in Sepsis
Naturally present antibacterial proteins play an important role in innate host defense. A synthetic peptide mimicking the C-terminal lipopolysacchari
- 1 November 2003
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 188 (9) , 1382-1393
Open AccessProtective Efficacy of CAP18106–138–Immunoglobulin G in Sepsis
Naturally present antibacterial proteins play an important role in innate host defense. A synthetic peptide mimicking the C-terminal lipopolysacchari